Ömer Fatih Ölmez

Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer

Bahadır Köylü, Nur Ilayda Genc, Mehmet Haluk Yücel, Anıl Yıldız et autres

tr (code pays fourni par la source)

A Composite Histopathologic Invasion Score Predicts Lymph Node Metastasis in Gastric Cancer

Ebru Karcı, Mahya Ahmadpour Youshanlui, Ferhat Özden, Ozgur Acikgoz et autres

tr (code pays fourni par la source)

Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

İrfan Çiçin, Taha Bahsi, Fatih Köse, Tulay Kus et autres

tr (code pays fourni par la source)

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

Bahadır Köylü, Ozde Melisa Celayir, Harun Muğlu, Orcun Can et autres

tr (code pays fourni par la source)

Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapy

Ebru Karcı, Ferhat Özden, Elif Kuzucular, ÖZGÜR AÇIKGÖZ et autres

tr (code pays fourni par la source)

Investigation of Predictive and Prognostic Factors in Metastatic Renal Cell Carcinoma (mRCC) Patients Receiving First-line Treatment: A Retrospective Single-center Experience

Jamshid Hamdard, Ebru Karcı, Özgür Açıkgöz, Ömer Fatih Ölmez

tr (code pays fourni par la source)

Unveiling the Uncommon: A Comprehensive Review and Case Report on Targeting Rare MET Fusions in NSCLC

Harun Muglu, Jamshid Hamdard, Banu Karaalioğlu, Erdem Sünger et autres

tr (code pays fourni par la source)

Investigating the feasibility of cascade genetic testing for BRCA1/2 in Türkiye: physicians' practices, barriers, and solutions

İrfan Çiçin, Tülay Kuş, Yesim Eralp, Yüksel Ürün et autres

Inflammation-Related Parameters in Lung Cancer Patients Followed in the Intensive Care Unit

Burcu Tunay, Ömer Fatih Ölmez, Ahmet Bılıcı, Ayberk Bayramgil et autres

tr (code pays fourni par la source)

Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program

Mehmet Alı Nahıt Şendur, Mutlu Hızal, Burcu Çakar, Oktay Halit Aktepe et autres

tr (code pays fourni par la source)

The Prognostic Roles of Systemic Inflammatory Markers Before Abiraterone or Enzalutamide Therapy in Metastatic Castration-Resistant Prostate Cancer

Harun Muğlu, Erdem Sünger, Lamia Şeker Can, Jamshid Hamdard et autres

tr (code pays fourni par la source)

Cytotoxic Lesion of the Corpus Callosum Associated with 5-Fluorouracil: A Case Report and Review of Literature

Maral Martin Mıldanoğlu, Ebru Engin Delipoyraz, Mehmet Haluk Yücel, Ömer Fatih Ölmez

tr (code pays fourni par la source)